SERCA2a gene therapy for the prevention of sudden cardiac death: A future theranostic for heart failure?

Sanjiv J. Shah; J. Andrew Wasserstrom

doi:10.1161/CIRCULATIONAHA.112.138321

SERCA2a gene therapy for the prevention of sudden cardiac death: A future theranostic for heart failure?

Sanjiv J. Shah, J. Andrew Wasserstrom^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	2047-2050
Number of pages	4
Journal	Circulation
Volume	126
Issue number	17
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.112.138321
State	Published - Oct 23 2012

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCULATIONAHA.112.138321

Cite this

@article{b87bafdb5606452d9ac8c6577693ddbf,

title = "SERCA2a gene therapy for the prevention of sudden cardiac death: A future theranostic for heart failure?",

author = "Shah, {Sanjiv J.} and Wasserstrom, {J. Andrew}",

year = "2012",

month = oct,

day = "23",

doi = "10.1161/CIRCULATIONAHA.112.138321",

language = "English (US)",

volume = "126",

pages = "2047--2050",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "17",

}

TY - JOUR

T1 - SERCA2a gene therapy for the prevention of sudden cardiac death

T2 - A future theranostic for heart failure?

AU - Shah, Sanjiv J.

AU - Wasserstrom, J. Andrew

PY - 2012/10/23

Y1 - 2012/10/23

UR - http://www.scopus.com/inward/record.url?scp=84867822429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867822429&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.112.138321

DO - 10.1161/CIRCULATIONAHA.112.138321

M3 - Review article

C2 - 23019292

AN - SCOPUS:84867822429

SN - 0009-7322

VL - 126

SP - 2047

EP - 2050

JO - Circulation

JF - Circulation

IS - 17

ER -

SERCA2a gene therapy for the prevention of sudden cardiac death: A future theranostic for heart failure?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this